Overview
Italy laser equipment maker's 2025 revenue rose 4.4% yr/yr to EUR 591 mln
Net profit for 2025 fell 15.9% yr/yr, impacted by discontinued operations and market factors
Net financial position improved, ending 2025 cash positive by EUR 172.2 mln
Outlook
El.En. forecasts revenue and operating profit growth for 2026
Result Drivers
MEDICAL SECTOR GROWTH - Revenue from the medical sector rose 4.4% yr/yr, with increased sales of surgical systems and DEKA-branded products
INDUSTRIAL SECTOR RECOVERY - Industrial sector revenue rose 4.3% yr/yr, with growth of 26% in Italy offsetting declines in other regions
Company press release: ID:nBIA7sL7x5
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
EUR 591 mln
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for El En SpA is €15.80, about 26% above its March 12 closing price of €12.54
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 17 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
